Wisp OMG Cream Review: Three Drugs, Two Strengths, and the Evidence Gap
Sort the symptom fit before choosing a treatment
This free tool separates physical arousal, low desire, orgasm difficulty, and menopause-related tissue symptoms, while flagging situations where online care is not the right starting point.
Affiliate disclosure: The HRT Index has affiliate relationships with Wisp and Winona. The Wisp links in this article are direct, non-affiliate editorial links, so we do not earn a commission from these clicks. The Winona link is affiliate and is disclosed beside the link. No commercial relationship changed the findings or placement on this page.
Wisp OMG Cream review verdict: is it worth considering?
Wisp OMG! Cream is a compounded prescription arousal cream containing sildenafil, pentoxifylline, and ergoloid mesylate. Wisp publishes 1% and 3% sildenafil strengths and says to apply it 30 minutes before sex. It may fit reduced physical arousal or sensitivity, not low desire or menopause-related tissue pain. Public pricing starts at $11 per month for three months.
The reason this Wisp OMG Cream review exists is simple: Wisp's public buying page names sildenafil, but its separate treatment guide names three prescription drugs. That formula gap matters more than another page of glowing testimonials.
Best for you if
- Your mind is interested, but your body is not responding with the same sensitivity, swelling, warmth, or lubrication it used to
- You want a prescription topical option rather than a daily desire medication
- You want a seller that publicly identifies the sildenafil concentration as 1% or 3%
- You want the choice between a one-time treatment and a subscription
- You are comfortable using a compounded medicine after reviewing the complete dispensed label and pharmacy information
Not for you if
- Your main problem is that you rarely want sex at all
- Your main problem is vaginal burning, persistent dryness, bleeding, or pain with penetration
- You want an FDA-approved finished product; OMG! Cream is compounded and is not FDA approved
- You take nitrates, riociguat, or another medication Wisp flags for interaction review
- You have one of the health conditions Wisp lists as a stop condition
- You are pregnant, trying to become pregnant, or breastfeeding
- You need the complete formula, strength-specific price, amount per application, dispensing pharmacy, and use count visible before medical intake
Wisp OMG! Cream at a glance
| Decision fact | What we verified |
|---|---|
| What it is | Compounded prescription topical cream for physical arousal and sensitivity |
| Active drugs | Sildenafil citrate, pentoxifylline, and ergoloid mesylate, per Wisp's treatment guide |
| Published strengths | Original 1% sildenafil and Extra Strength 3% sildenafil |
| Public price display | Starting at $11 per month for three months |
| Buying options | One-time treatment or subscription |
| Exact one-time and 3% prices | Not exposed in the public page text we could verify; confirm before payment |
| How Wisp says to use it | Apply to the clitoral and vaginal areas 30 minutes before anticipated sexual activity and massage gently |
| Public availability claim | All 50 states, with free discreet delivery |
| FDA approved? | No. It is compounded |
| Trial of Wisp's exact formula? | No |
| Subscription timing | Wisp's guide says refills are scheduled every 90 days, subject to a refill visit |
| Cancellation | At least 48 hours before the next refill or renewal period |
| Refunds | Product sales are generally final, with narrow exceptions in Wisp's terms |
| Last checked | 13 August 2026 |
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
Is Wisp OMG! Cream right for physical arousal, low desire, dryness, or orgasm trouble?
OMG! Cream is built for the physical-arousal column: reduced genital sensation, less swelling, and less lubrication during arousal. It is not a tissue-repair treatment for genitourinary syndrome of menopause, and it does not directly treat low desire. Orgasm difficulty may overlap with arousal trouble, but the only randomized trial found its clearest exploratory signal in women without concomitant orgasmic dysfunction.
This is the most important decision on the page. The easiest way to waste money here is not buying a bad product. It is buying a product for the wrong problem.
"Sex drive" can hide at least four separate problems:
- Desire — wanting sex or feeling open to it
- Mental arousal — feeling turned on in your head
- Physical arousal — genital swelling, warmth, lubrication, and sensitivity
- Orgasm — reaching the finish line after arousal and stimulation
They overlap, but they are not interchangeable. The Menopause Society separates sexual concerns into desire, arousal, orgasm, and pain for the same reason: each can break down differently and may need a different response.
Which problem sounds most like yours?
| What you are experiencing | Is a blood-flow cream the right category? | Better next step |
|---|---|---|
| "I want sex. My body is not responding." Less sensitivity, swelling, or natural lubrication once you are already aroused | Possibly. This is the closest fit for OMG! Cream's intended role | Keep reading and compare the formula, evidence, and safety flags |
| "I barely think about sex anymore." Desire itself is missing | Usually not by itself. Arousal and desire are different domains | Discuss low-desire causes and treatment options with a clinician; see libido and sexual health in menopause |
| "It burns, feels dry all day, or hurts with penetration." | No — not as the main treatment. Menopause-related dryness and pain can reflect thinning, less elastic tissue | Start with vaginal estrogen and local-treatment options and seek an exam for bleeding, sores, severe pain, or persistent symptoms |
| "I become aroused, but I cannot finish." | Maybe, but the evidence is weaker than the marketing sounds | Read the trial section before treating an orgasm problem as a blood-flow problem |
| "Several of these are true." | Do not force yourself into one box | Use Find My HRT Path to sort the symptom pattern and identify when in-person care should come first |
Two rows send you away from this product. That is intentional. A compounded arousal cream bought for estrogen-depleted tissue or absent desire will feel like a failed product when the real failure happened one step earlier: the category was wrong.
Not sure which row is yours?
Most women do not land cleanly in one column. Use The HRT Index's Find My HRT Path tool to separate desire, physical arousal, orgasm, and menopause-related tissue symptoms — and to flag when online care is not the right starting point.
What is actually in Wisp OMG! Cream?
Wisp's current treatment guide names three prescription drugs: sildenafil citrate, pentoxifylline, and ergoloid mesylate. The public product page names sildenafil and publishes the 1% and 3% strengths, but it does not display the other two active drugs in the visible buying-page text. That is the defining transparency tradeoff in this review.
The verified formula
| Drug in Wisp's guide | What is FDA approved | What is not FDA approved |
|---|---|---|
| Sildenafil citrate | Oral sildenafil products for specific indications including erectile dysfunction and pulmonary arterial hypertension | Wisp's compounded genital cream and its use for female arousal |
| Pentoxifylline | Oral extended-release tablets for intermittent claudication associated with chronic occlusive arterial disease | A topical genital formulation or treatment for female sexual function |
| Ergoloid mesylate | Older oral labeling for selected symptoms involving decline in mental capacity of undetermined cause | A topical genital formulation or treatment for female sexual function |
Wisp describes the compounded combination as intended to improve local blood flow. That is the formula's logic. It is not FDA approval evidence, and it is not proof that the three-drug combination works better than sildenafil alone.
The buying page and treatment guide do not tell the same story
| Question | Public product page | Separate Wisp treatment guide |
|---|---|---|
| Names sildenafil | Yes | Yes |
| Names pentoxifylline | No in the visible product-page text | Yes |
| Names ergoloid mesylate | No in the visible product-page text | Yes |
| Publishes sildenafil strength | Yes: 1% and 3% | Yes: 1% and 3% |
| States that it is compounded | Not in the visible product-page text we reviewed | Yes |
| Gives the application timing | FAQ heading appears, but answer is not exposed in the public text | Yes: 30 minutes before anticipated sexual activity |
| Lists stop conditions and medication interactions | Not in the visible product-page text | Yes |
Here is the damaging admission, plainly:
Wisp does not put the full three-drug formula or the compounded status in the visible text of the page where you start the purchase. You have to reach the separate treatment guide to see it.
If buying-page formula transparency is your top priority, Alloy publishes its full ingredient list, gram count, and stated use count directly on its O-Mazing page. That is a real advantage.
But Wisp publishes something Alloy does not: the sildenafil concentration. Wisp's 1% and 3% numbers let you see the difference between its versions and compare the concentration — carefully, not equivalently — with the 3.6% investigational cream used in the published trial.
That is the trade: Wisp gives you the concentration that matters for evidence comparison, but separates the complete formula from the buying page.
Is peppermint oil in Wisp OMG! Cream?
Wisp's current treatment guide does not list peppermint oil among the three actives, and Wisp's own educational page says OMG! Cream does not rely on peppermint or essential oils for a tingling effect. Alloy's O-Mazing formula does offer peppermint oil as an optional ingredient.
Do not copy the formula, timing, condom, oral-sex, or partner instructions from one "scream cream" to another. These products are not interchangeable.
Is Wisp OMG! Cream FDA approved?
No. Wisp OMG! Cream is compounded and is not FDA approved. The FDA has not reviewed this finished cream for safety, effectiveness, or quality before marketing. There is also no FDA-approved medication specifically for female sexual arousal disorder, although FDA-approved medicines exist for a different condition: acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.
What "not FDA approved" means
It means:
- The finished Wisp formula did not go through FDA premarket approval
- The FDA did not verify this cream's safety, effectiveness, or quality before it was marketed
- Evidence from approved oral sildenafil products does not establish that this topical three-drug cream works
- Evidence from Daré's 3.6% single-drug cream does not establish that Wisp's different formula works
- The identity and regulatory pathway of the dispensing pharmacy matter
It does not mean:
- The product is automatically fake or counterfeit
- Compounding has no legitimate role in medicine
- A licensed prescriber can never decide that a compounded product fits an individual patient
- This specific Wisp product has been proven unsafe
The FDA says compounded drugs can serve an important patient need when an FDA-approved drug is not medically appropriate. It also says compounded drugs are not generics and should not be presented as though they are approved equivalents.
Approved drugs inside an unapproved product do not make the finished cream approved
This is where the language gets slippery.
Sildenafil exists in FDA-approved oral products. Pentoxifylline exists in an FDA-approved oral tablet. Ergoloid mesylates have appeared in approved oral labeling. Wisp combines those drugs in a topical genital cream for a different purpose.
That finished cream is not a generic version of Viagra, not interchangeable with a Viagra tablet, and not "clinically proven" because another sildenafil formulation entered a trial. We will not use those shortcuts.
If knowing it is compounded does not change your decision
See Wisp's current 1% and 3% options and check availability →
Direct, non-affiliate Wisp link. Prescription required. A licensed provider decides whether treatment is appropriate.Still weighing compounded against FDA-approved medicine? Read the FDA explanation in the source list before intake.
How much does Wisp OMG! Cream cost in 2026?
Wisp's public page displays OMG! Cream as starting at $11 per month for three months and offers either a one-time treatment or a subscription. The visible page text does not expose the exact one-time price, the 3% Extra Strength price, the quantity per bottle, or a verified use count. Confirm the total charged today before submitting payment.
A real cost-per-use figure cannot be calculated from the current public data. Wisp does not publicly expose every variable required: the exact total for each strength and purchase option, the quantity dispensed, and the amount used per application. Any precise per-use number would be manufactured math.
The provider-stated vs verified price ledger
| Price question | What Wisp publicly states | What you still need to confirm |
|---|---|---|
| Lowest displayed price | Starting at $11 per month for three months | Which strength and purchase option earns that display |
| One-time treatment available | Yes | Exact one-time total |
| Subscription available | Yes | Exact initial charge, renewal charge, and strength selected |
| Original 1% price | Not separated in the visible public text | Confirm during intake or checkout |
| Extra Strength 3% price | Not separated in the visible public text | Confirm during intake or checkout |
| Bottle size | Not exposed in the visible public text we verified | Read the checkout and dispensed label |
| Uses per bottle | Not exposed in the visible public text we verified | Ask for amount per application and total dispensed quantity |
| Cost per use | Cannot be calculated responsibly from the public data | Divide the confirmed total by the label-based number of applications |
| Delivery | Wisp states free discreet delivery | Confirm your address is serviceable |
| Availability | Wisp states all 50 states | Clinical approval still depends on your intake |
Do not let the $11 display become the only number you remember. The number that matters is the complete charge for the version and purchase model you select.
Before paying, capture four numbers:
- The strength: 1% or 3%
- The amount charged today
- The next refill amount and date, if any
- The dispensed quantity and amount per application
Only then can you calculate a real cost per use.
Does Wisp still look like the right category for you?
Check the current price attached to the exact strength and purchase option →
Review the total due today, not only the monthly display. Direct, non-affiliate Wisp link.
Does Wisp OMG! Cream actually work?
No clinical trial has tested Wisp's exact three-drug formula. The closest published randomized trial tested a different proprietary cream containing 3.6% sildenafil alone. In the full study population, neither coprimary endpoint nor the secondary endpoint showed a statistically significant advantage over placebo. An exploratory subgroup produced a signal, but it does not prove that Wisp works.
That is the answer the category usually tries to step around.
What the RESPOND trial actually tested
The 2024 RESPOND study was a phase 2b, randomized, double-blind, placebo-controlled trial in 200 healthy premenopausal women with female sexual arousal disorder.
It tested:
- A proprietary 3.6% sildenafil cream
- Sildenafil as the active drug, not Wisp's three-drug blend
- A 2-gram application split between external genital tissue and the distal vagina
- Use about 10 to 20 minutes before a sexual event
- Up to nine applications per month
- Twelve weeks of double-blind treatment after no-drug and placebo run-in periods
Wisp is different in formula, base, application instructions, published concentration, and likely dose delivered. Wisp also markets to women in menopause, while the randomized phase of RESPOND enrolled premenopausal women.
The main efficacy result was negative
In the intention-to-treat population, the sildenafil group improved numerically more on arousal sensation, but the difference did not reach statistical significance. The two coprimary endpoints and the secondary endpoint did not separate significantly from placebo.
The researchers then examined an exploratory post-hoc subset: women with arousal disorder alone or arousal disorder with decreased desire, but without the other concomitant problems that diluted the signal. In that subset, the arousal-sensation score improved significantly, and several exploratory desire, orgasm, distress, and interpersonal measures also improved.
That subgroup is useful for deciding what a future phase 3 trial should test. It is not the same thing as a successful primary endpoint.
The orgasm problem collides with the marketing
Wisp's product page talks heavily about better orgasms and features seller-hosted orgasm stories. The trial's conclusion was more selective: the strongest exploratory benefit appeared among women without concomitant orgasmic dysfunction.
That does not prove a blood-flow cream cannot help anyone reach orgasm. It does mean a woman whose only problem is orgasm should not read Wisp's marketing as though the trial confirmed that use.
The placebo run-in makes the negative main result harder to ignore
Before randomization, participants used placebo cream for a month. Women with a predetermined placebo response were not randomized into the double-blind phase.
Even after that filter, the main efficacy endpoints did not significantly separate from placebo.
Sexual response is unusually sensitive to expectation, attention, context, relationship factors, and the act of trying something new. That does not make a positive personal experience fake. It is exactly why seller-hosted five-star stories cannot substitute for a controlled trial.
What the safety trial found
The companion safety paper was more reassuring:
- 99 women used sildenafil cream and 94 used placebo during the double-blind phase
- Treatment-emergent events were mild or moderate
- Treatment-related event rates did not differ significantly between groups
- Application-site discomfort was the most common treatment-related event
- Partner-reported events were uncommon and did not differ significantly between groups
- The active-cream group recorded 1,357 sexual experiences during the double-blind period
That supports further development of Daré's 3.6% product. It does not establish the safety of Wisp's pentoxifylline-and-ergoloid combination, because those ingredients were not in the trial cream.
How much weight should each kind of evidence carry?
| Evidence | Does it exist? | What it can tell you |
|---|---|---|
| Trial of Wisp's exact formula | No | Nothing product-specific; no such trial was found |
| Randomized trial of proprietary 3.6% sildenafil-only cream | Yes | The full-population efficacy endpoints were negative; an exploratory subset showed a signal |
| Safety data for proprietary 3.6% sildenafil-only cream | Yes | Reassuring for that formulation and studied population, not proof for Wisp's three-drug mix |
| Wisp's treatment guide | Yes | Formula, strengths, instructions, listed conditions, interactions, and side effects |
| Wisp's marketing page | Yes | What Wisp says the product is intended to do, not proof that it will happen |
| Seller-hosted reviews | Yes | Individual anecdotes selected and displayed by the seller |
| Trial of Wisp 1% versus Wisp 3% | No | No evidence that 3% produces three times the benefit or a predictable response advantage |
The evidence is not zero. It is simply not Wisp-specific, and its strongest main result is not the one the marketing would lead you to expect.
Who should not use Wisp OMG! Cream?
Wisp's treatment guide lists six health conditions that should trigger stopping and contacting Wisp or a clinician, plus six medication or substance categories that require review before use. It also says the compounded cream is not recommended during pregnancy or breastfeeding. These instructions belong in the decision, not in fine print after payment.
The six conditions in Wisp's guide
Wisp tells patients to stop and contact the company or a doctor if they have or develop:
- Retinitis pigmentosa
- Cerebral or retinal hemorrhage
- Peripheral vascular disease
- Coronary heart disease
- Uncontrolled hypertension
- Severe liver or kidney impairment
Wisp says the list may not be complete.
The medications and substances Wisp says to raise before use
Wisp's guide lists:
- Nitrates, including nitroglycerin and other nitric oxides
- Guanylate cyclase stimulators, including riociguat
- Alpha blockers, beta blockers, and other antihypertensives
- CYP3A4 inhibitors, with ritonavir, ketoconazole, and erythromycin given as examples
- Ergot-type medicines or 5-HT1 agonists, including triptans such as sumatriptan, used within 24 hours
- Nicotine
Do not turn that into a self-screening exercise. Put every prescription, over-the-counter medicine, supplement, nicotine product, and recreational substance on the intake form. Sildenafil and nitrates are a particularly serious combination because of the risk of a sharp blood-pressure drop.
Pregnancy and breastfeeding: Wisp's wording needs context
Wisp's guide says the product is not recommended in pregnancy or breastfeeding because it contains pentoxifylline, which the guide calls "Category C."
That is Wisp's current wording, but the FDA replaced the old A, B, C, D, and X pregnancy-letter system with narrative risk summaries. Do not interpret the letter as a modern safety grade. The actionable point remains the same: if you are pregnant, trying to become pregnant, or breastfeeding, do not treat this as a checkout decision. Discuss it with the prescriber and follow the current dispensed labeling.
Side effects Wisp lists
Wisp's guide names:
- Itching
- Redness
- Scaling or dryness
- Headache
- Burning or irritation at the application site
- Possible flushing, dizziness, or stomach upset if systemic absorption occurs
- Rare changes in mood or thinking, bleeding risk, or circulation
Wisp says to avoid broken skin and wash your hands after use. It also tells patients to contact a doctor for severe skin reactions, fainting, unusual bleeding, or sudden changes in mood or circulation.
The third ingredient deserves a direct question, not a panic headline
Ergoloid mesylate is the ingredient almost nobody expects to see in a sexual-health cream.
Its U.S. oral labeling concerns selected symptoms involving decline in mental capacity of undetermined cause. It has no FDA-approved topical genital form and no FDA-approved sexual-function indication. Wisp does not publish its concentration on the public product page or treatment guide.
European regulators reviewed dihydroergotoxine — another name for ergoloid mesylate — with several ergot derivatives in 2013 and restricted certain oral systemic uses because the benefits did not outweigh risks including fibrosis and ergotism.
That was not an action against Wisp, compounded creams, topical genital use, or the United States. It does not prove that Wisp's cream creates those risks. It does prove that the ingredient has a regulatory history worth disclosing, especially when the concentration and systemic exposure from Wisp's formula are not published.
Ask one clean question during intake:
How much ergoloid mesylate is delivered in one application, and what evidence supports including it in this topical formula?
That question is not alarmism. It is what informed consent looks like when a formula contains an unexpected prescription drug.
Where this page belongs in your safety hierarchy
- The label and pharmacy information on the medicine you receive
- Your prescribing clinician and pharmacist
- Wisp's product-specific treatment information
- This review
We are fourth, and we should be. If your dispensed label conflicts with this page, the label wins.
Should you choose Wisp Original 1% or Extra Strength 3%?
Wisp publishes two sildenafil concentrations: 1% Original and 3% Extra Strength. Three percent contains three times the sildenafil concentration of 1%, but no Wisp trial shows three times the benefit, duration, or response rate. A provider should choose the strength after reviewing your symptoms, medications, health history, and tolerance for local irritation.
What Wisp says about the two versions
Wisp's product page presents Original 1% as the standard formula and Extra Strength 3% as the stronger option. Its comparison graphic positions the 3% version around menopause, medication-related changes such as SSRIs, and reduced sensitivity.
That is provider positioning, not comparative clinical evidence.
Concentration is not efficacy math
This is the mistake the page must prevent:
3% is three times the concentration of 1%. It is not three times the effect.
There is no published Wisp dose-response study. We found no randomized comparison of Wisp 1% versus Wisp 3%, no published delivered dose per application, and no verified strength-specific price in the public page text.
The 3% concentration is numerically closer to Daré's 3.6% investigational cream than 1% is. That does not make the products equivalent. Daré's trial used a different single-active formulation, a defined 2-gram dose, a different application map, and different timing.
Questions to ask before accepting a strength
- Is my main problem reduced physical arousal, reduced sensation, low desire, pain, dryness, or orgasm?
- How many milligrams of sildenafil are delivered in one application of the 1% and 3% versions?
- Do pentoxifylline or ergoloid amounts change between versions?
- What is the exact price of the prescribed strength?
- What is the maximum application frequency on my label?
- Should I begin with 1% if I am prone to burning or irritation?
- What should I do if I feel dizziness, numbness, pain, or persistent burning?
If the formula still fits what you are trying to solve
Check which Wisp strength a licensed provider considers appropriate →
Confirm the strength-specific price and delivered dose before payment. Direct, non-affiliate Wisp link.
How do you use Wisp OMG! Cream?
Wisp's current treatment guide says to apply the prescribed cream directly to the clitoral and vaginal areas 30 minutes before anticipated sexual activity and massage it in gently. Use only the amount, location, and maximum frequency on your dispensed label. Wisp's public FAQ lists oral-sex and partner-contact questions, but its answers are not exposed in the public text we could verify.
The instructions we could verify
- Timing: 30 minutes before anticipated sexual activity
- Location: clitoral and vaginal areas
- Method: massage in gently
- Broken skin: avoid applying there
- After applying: wash your hands
- Storage: cool, dry, and away from light
- Expiration: do not use beyond the date on the dispensed label
- Subscription refills: Wisp's guide says every 90 days, subject to a refill visit
What we could not responsibly paraphrase
Wisp's product page visibly asks:
- Is it safe before oral sex?
- What are the risks if a male partner contacts the cream?
- How often can it be used?
- Can it be used long term?
- Is it only for vaginal use, or can it be used anally?
The answers sit inside collapsed page elements and were not exposed in the public text available during our 13 August 2026 verification. We are not going to replace product-specific instructions with assumptions or with another company's directions.
Before first use, get explicit answers from the dispensed label, pharmacist, or Wisp clinician about:
- Oral contact and whether the product should be washed or wiped off first
- Partner exposure, especially if the partner uses nitrates, blood-pressure medicine, or has an ingredient allergy
- Condom and barrier compatibility
- Toy compatibility
- External versus internal application boundaries
- Maximum applications per day and per week
- How long to wait before reapplying
What to check when the package arrives
| Label check | Why it matters |
|---|---|
| 1% or 3% strength | Confirms you received the prescribed version |
| Amount per application | Concentration alone does not tell you the delivered dose |
| Full active and inactive ingredient list | Identifies all drugs and the cream base |
| Exact application area | External and internal directions should never be guessed |
| Maximum frequency | Prevents self-escalation |
| Oral-contact and partner instructions | Product-specific exposure guidance matters |
| Condom or barrier compatibility | Cream bases can differ |
| Dispensing pharmacy name and address | Identifies who prepared the medicine |
| Beyond-use date | Compounded products use pharmacy-assigned dating |
Never apply extra because the first attempt felt weak. Never move yourself from 1% to 3%. Never combine it with another sildenafil or PDE-5 product unless the prescriber explicitly approves it.
How does Wisp compare with Alloy, Cake, Winona, and DARE to PLAY?
Wisp's clearest advantage is publishing its 1% and 3% sildenafil concentrations. Its clearest weakness is separating the full three-drug formula from the public buying page. Alloy publishes the most complete formula and quantity information before intake. Winona publishes a $79 order price but no strength. Daré's 3.6% formula is the studied product, but its commercial rollout and current fulfillment must be confirmed before treating it as an ordinary retail alternative.
What each public page tells you before medical intake
| Product | Public price information | Sildenafil strength shown? | Active drugs publicly named | Quantity or use count shown? | Compounded status | Key transparency finding |
|---|---|---|---|---|---|---|
| Wisp OMG! Cream | Starts at $11/month for 3 months; one-time or subscription | Yes: 1% and 3% | Product page: sildenafil. Treatment guide: sildenafil, pentoxifylline, ergoloid mesylate | No verified public quantity/use count | Yes, in treatment guide | Best concentration disclosure; complete formula is separated from buying page |
| Alloy O-Mazing | $29.99/month; one 3-month bottle billed at $89.97 | No | Sildenafil, pentoxifylline, ergoloid mesylates; optional peppermint oil; base ingredients listed | 15 g; up to 30 uses | Described as a custom prescription blend; confirm dispensing details | Most complete buying-page formula and quantity disclosure |
| Hello Cake O-Cream Rx | Price depends on selected dose quantity; confirm in cart | Yes: 1% and 3% | Sildenafil is named; product is identified as compounded | Six doses per standard order shown on product page | Yes on product page | Strong strength and compounding disclosure; price must be matched to selected quantity |
| Winona Sildenafil Arousal Cream | $79 per order | No | Sildenafil and pentoxifylline | No public use count found | Compounded in the USA | Clear order price, but no public strength or dose count |
| DARE to PLAY 3.6% | No completed-fulfillment price publicly verified as of 13 August 2026 | Yes: 3.6% | Sildenafil only | Confirm through current prescribing channel | 503B compounded; not FDA approved | Closest to the studied formulation; pre-fulfillment prescribing was announced, so confirm that dispensing has begun before treating it as a retail alternative |
Provider-stated facts checked 12–13 August 2026. Public pages can change. Confirm the exact dispensed product, pharmacy, and checkout total.
Where Wisp wins
- It publishes 1% and 3% concentrations
- It offers one-time and subscription paths
- It states availability in all 50 states
- Its separate treatment guide is unusually detailed about conditions, interactions, side effects, and treatment failure
Where Wisp loses
- The public product page does not name two of the three active drugs
- The public page text does not expose the exact one-time or strength-specific price
- The public page text does not expose bottle size, amount per application, or use count
- We could not confirm whether its dispensing pathway is a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility
- There is no trial of Wisp's exact formula
The 503A versus 503B question
The FDA distinguishes two common compounding pathways:
- 503A: patient-specific compounding by a state-licensed pharmacy, federal facility, or physician under applicable conditions. These compounders are primarily overseen day to day by state boards and are not subject to current good manufacturing practice requirements under the same framework as 503B facilities.
- 503B: an FDA-registered outsourcing facility subject to current good manufacturing practice requirements and FDA risk-based inspection.
That does not make every 503B product good or every 503A product bad. It is a meaningful quality-oversight difference, and Wisp should identify the dispensing pharmacy on the label.
Our disclosure, where it matters
The HRT Index has affiliate relationships with Wisp and Winona. This article uses direct, non-affiliate links to Wisp; the Winona link is affiliate. Alloy, Cake, and Daré are not affiliate links on this page.
Winona's page publishes a clear $79 order price and names sildenafil plus pentoxifylline, but it does not publish the strength or a use count. We are not going to move a commission-bearing option above Wisp on a transparency table when the public facts do not support it.
If buying-page formula transparency is your priority
See Alloy's full published ingredient list and bottle quantity →
Direct, non-affiliate Alloy link.
If you want an arousal cream inside a broader menopause-care relationship
Check Winona's current eligibility and order details →
We earn a commission on this link. Winona's cream is compounded, and its public page does not disclose the strength or use count.
Is Wisp OMG! Cream a subscription, and can you cancel or get a refund?
Wisp offers a one-time treatment and a subscription. Its terms require cancellation at least 48 hours before the next refill or renewal period to avoid the next charge. Product sales are generally final, with narrow situations in which Wisp may provide a refund or replacement. A one-time treatment avoids renewal risk, but the exact one-time price must be confirmed.
What Wisp's terms say about refunds
Wisp says product sales are final and that it generally does not provide refunds, returns, or exchanges. It may decide to provide a refund or replacement if:
- A product is out of stock
- A prescription product is unavailable at local pharmacies
- A product arrives damaged, broken, or defective
- You do not receive a product you purchased
Wisp can request documentation and may choose replacement instead of a refund. It can also issue a refund at its sole discretion.
"It did not work for me" is not one of the listed exceptions. That matters more for this category because the exact Wisp formula has no product-specific efficacy trial.
How Wisp subscription renewal works
The treatment guide says subscription customers are scheduled for a refill every 90 days, subject to a refill visit that screens for side effects.
Wisp's broader terms add an important detail: a prescription subscription does not renew until the patient completes the renewal intake form and a licensed practitioner reviews it. If a valid prescription is not in place, Wisp says the prescription renewal is not processed or billed until one is issued and processed.
To cancel:
- Submit cancellation at least 48 hours before the next refill or renewal period
- Use the patient portal or email
support@hellowisp.com - Cancellation stops future renewal; it does not create a refund for an order already processed
- Put the deadline on your calendar when you order
The lower-friction way to test the fit
Compare Wisp's one-time and subscription totals before selecting either →
A one-time treatment removes the refill deadline. Confirm the exact one-time price before payment. Direct, non-affiliate Wisp link.
Can you trust the reviews of Wisp OMG! Cream?
Wisp's product page displays six seller-hosted five-star reviews dated from February 2023 through August 2024. The nearby 4.3 score is labeled as Wisp company reviews, not an OMG! Cream product rating. None of the displayed product reviews identifies experience with the newer 3% version, and testimonials cannot establish formula accuracy, FDA status, safety, or efficacy.
What is actually on Wisp's page
The six displayed product reviews are dated:
- 13 February 2023
- 24 August 2023
- 14 September 2023
- 14 September 2023
- 22 August 2024
- 27 August 2024
All six are five stars. They sit beneath a separate 4.3 out-of-5 company-review display.
That does not prove manipulation. It does mean you should not read the company-wide number as a product rating, and you should not assume the six featured stories represent typical results.
What reviews can and cannot tell you
A review can tell you what one person felt, how long delivery took for that order, or whether that person liked the texture.
A review cannot verify:
- Which strength the person received
- The amount applied
- The full formula in that bottle
- Whether the person had physical-arousal trouble, low desire, pain, or orgasmic dysfunction
- Whether a medication interaction was present
- Whether a compounded product is FDA approved
- What proportion of users respond
The evidence section should move your decision more than the star stories. That is not cold or cynical. It is the difference between an anecdote and a denominator.
What should you check before paying for Wisp OMG! Cream?
Confirm nine things before payment: the symptom category, prescribed strength, total charged today, one-time versus subscription selection, renewal amount and date, three-drug formula, medication interactions, dispensing pharmacy, and what happens if the provider does not prescribe. After delivery, verify the amount per application, maximum frequency, partner instructions, and beyond-use date on the label.
The pre-pay checklist
- [ ] My main problem is physical arousal or sensation, not unexplained bleeding, persistent pain, tissue burning, or absent desire alone
- [ ] The prescribed strength is clear: 1% or 3%
- [ ] I have the exact total due today, not only the $11 monthly display
- [ ] I know whether I selected one-time or subscription
- [ ] I recorded the refill amount and date, if subscribing
- [ ] I know the 48-hour cancellation deadline
- [ ] I disclosed every medication, supplement, nicotine product, and relevant substance
- [ ] I checked Wisp's six listed stop conditions
- [ ] I asked what happens financially if the clinician declines to prescribe
- [ ] I will verify the dispensing pharmacy, full formula, amount per application, maximum frequency, partner instructions, and beyond-use date when the medicine arrives
The one sentence to use at intake
You do not need medical vocabulary. You need to stop compressing every concern into "low libido."
"I still want sex, but my body is responding differently — less sensation and less physical arousal. My main problem is not pain, and it is not that I have lost interest."
Or say the opposite if the opposite is true. The point is accuracy, not saying the sentence that earns a prescription.
Wanting help with this is not silly, and it is not vanity. Menopause can affect desire, arousal, orgasm, pain, sleep, mood, relationships, and genital tissue at the same time. Bringing a written symptom map is how you keep a short appointment from collapsing all of that into one vague word.
Before you choose a product, make sure you are solving the right problem
Use Find My HRT Path to sort physical arousal, low desire, orgasm difficulty, and menopause-related tissue symptoms →
The tool also flags situations where online care is not the right starting point.
Frequently asked questions
What is in Wisp OMG! Cream?
Wisp's current treatment guide names sildenafil citrate, pentoxifylline, and ergoloid mesylate. Its public product page prominently names sildenafil and publishes 1% and 3% strengths but does not name the other two active drugs in the visible buying-page text.
Is Wisp OMG! Cream FDA approved?
No. It is a compounded prescription product, and compounded drugs are not FDA approved. The FDA has not verified this finished cream's safety, effectiveness, or quality before marketing.
Is Wisp OMG! Cream the same as Viagra?
No. Sildenafil exists in FDA-approved oral products, including Viagra, but Wisp's topical three-drug compounded cream is not a generic Viagra product and is not interchangeable with an approved sildenafil tablet.
How much does Wisp OMG! Cream cost?
Wisp publicly displays a starting price of $11 per month for three months and offers one-time or subscription treatment. The exact one-time amount and the strength-specific 1% and 3% prices were not exposed in the public page text we could verify. Confirm the total before payment.
How much does Wisp OMG! Cream cost per use?
A reliable cost per use cannot be calculated from the current public data because the visible Wisp pages do not confirm the bottle quantity, amount per application, or use count. Calculate it only after you have the checkout total and label-based number of applications.
How long does Wisp OMG! Cream take to work?
Wisp's current treatment guide says to apply it 30 minutes before anticipated sexual activity. Follow the timing on the dispensed label rather than shorter estimates from reviews of this or other creams.
Does Wisp OMG! Cream increase libido?
It is intended to support physical arousal and sensitivity through local blood-flow effects. That is not the same as directly treating low desire. Wisp's own educational content makes the same distinction: the cream may make sex more physically pleasurable, but it does not directly treat the causes of low libido.
Does Wisp OMG! Cream help with vaginal dryness?
Wisp markets support for lubrication during arousal. That is different from treating persistent dryness, burning, tissue thinning, or pain associated with genitourinary syndrome of menopause. Those symptoms deserve a separate local-treatment discussion and sometimes an in-person exam.
Does Wisp OMG! Cream help with orgasm?
It may help some people if reduced physical arousal or sensation is blocking orgasm, but Wisp's exact formula has not been tested in a randomized trial. In the closest trial, the strongest exploratory benefit appeared among women without concomitant orgasmic dysfunction.
What is the difference between Wisp Original 1% and Extra Strength 3%?
The published difference is sildenafil concentration: 1% versus 3%. That does not mean 3% is three times as effective. No Wisp dose-response trial was found, and the delivered amount per application and strength-specific price should be confirmed before treatment.
Who should not use Wisp OMG! Cream?
Wisp's guide lists retinitis pigmentosa, cerebral or retinal hemorrhage, peripheral vascular disease, coronary heart disease, uncontrolled hypertension, and severe liver or kidney impairment as stop conditions. It also flags nitrates, riociguat, blood-pressure medicines, CYP3A4 inhibitors, ergot medicines or triptans within 24 hours, nicotine, pregnancy, and breastfeeding for review.
Is Wisp OMG! Cream safe before oral sex or for a partner?
Wisp's product page lists these questions, but the answers were not exposed in the public text we could verify. Use the dispensed label or get a direct answer from the Wisp clinician or pharmacist before oral contact or partner exposure. Do not borrow instructions from Alloy, Cake, Winona, or Daré because the formulas and bases differ.
Can you cancel a Wisp OMG! Cream subscription?
Yes. Wisp's terms require cancellation at least 48 hours before the next refill or renewal period. Cancellation can be submitted through the patient portal or by emailing support@hellowisp.com.
Can you get a refund if Wisp OMG! Cream does not work?
Wisp's listed refund or replacement situations concern out-of-stock or unavailable products, damaged or defective delivery, and non-delivery. Lack of effect is not a listed exception. Wisp says refunds otherwise remain at its discretion and does not accept returns.
Is Wisp OMG! Cream available in every state?
Wisp's public product page states that its service is available in all 50 states. That does not guarantee a prescription; a licensed provider still decides whether treatment is appropriate after intake.
What we actually verified
On 13 August 2026, we checked:
- Wisp's live OMG! Cream product page
- Wisp's live OMG! Cream treatment guide
- Wisp's Terms of Service
- Wisp's Better Sex category page and current promotional display
- The FDA's current compounding guidance
- The FDA's current pregnancy and lactation labeling framework
- The peer-reviewed RESPOND efficacy paper
- The peer-reviewed RESPOND safety paper
- Current DailyMed labeling for sildenafil, pentoxifylline, and ergoloid mesylates
- The European Medicines Agency's ergot-derivative referral documents
- The Menopause Society's sexual-health and genitourinary-syndrome resources
- Current public product pages for Alloy, Hello Cake, Winona, and Daré
We did not buy the product, complete Wisp's medical intake, enter a payment method, or receive a dispensed bottle. Anything dependent on checkout or the pharmacy label is identified as unconfirmed rather than guessed.
The unresolved facts that still matter
- The exact one-time price
- The exact 1% and 3% price grid
- The quantity dispensed
- The amount per application
- The verified number of applications per container
- The concentrations of pentoxifylline and ergoloid mesylate
- Whether those two concentrations change between the 1% and 3% versions
- The identity and 503A or 503B status of the dispensing pharmacy
- The exact product-specific instructions for oral contact, partner exposure, condoms, and maximum frequency
- The exact amount charged if a clinician declines to prescribe
Those are not filler caveats. They are the remaining pieces a buyer needs to close before payment or first use.
How we work: The HRT Index Verification Standard is our documented process. We read every published price, separate FDA-approved from compounded options, verify state availability and insurance, and re-check on a fixed schedule, with top providers reviewed monthly and the full roster quarterly. We do not publish numeric scores. We evaluate every provider on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access.
Money: The HRT Index has affiliate relationships with Wisp and Winona. The Wisp links in this article are direct, non-affiliate editorial links. The Winona link is commission-bearing and disclosed beside the link. Alloy, Hello Cake, and Daré links are non-affiliate on this page.
Sources
- Wisp — OMG! Cream for Female Arousal. Checked 13 August 2026.
- Wisp — OMG! Cream 1% and 3% Extra Strength Treatment Guide. Checked 13 August 2026.
- Wisp — Terms of Service. Checked 13 August 2026.
- Wisp — Is There a Viagra for Women?. Checked 13 August 2026.
- U.S. Food and Drug Administration — Compounding and the FDA: Questions and Answers. Checked 13 August 2026.
- U.S. Food and Drug Administration — Pregnancy and Lactation Labeling Resources. Checked 13 August 2026.
- Johnson I, Thurman AR, Cornell KA, et al. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstetrics & Gynecology. 2024;144(2):144–152. PMID 38889431.
- Thurman AR, Johnson I, Cornell KA, et al. Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorder. The Journal of Sexual Medicine. 2024;21(9):793–799. PMID 39079074.
- DailyMed — Ergoloid Mesylates oral tablet labeling. Checked 13 August 2026.
- DailyMed — Pentoxifylline extended-release tablet labeling. Checked 13 August 2026.
- DailyMed — Sildenafil prescribing information. Checked 13 August 2026.
- European Medicines Agency — Ergot derivatives referral. Checked 13 August 2026.
- The Menopause Society — Sexual Health. Checked 13 August 2026.
- The Menopause Society — Genitourinary Syndrome of Menopause. Checked 13 August 2026.
- Alloy — O-Mazing. Checked 13 August 2026.
- Hello Cake — O-Cream Rx. Checked 13 August 2026.
- Winona — Sildenafil Arousal Cream. Checked 13 August 2026.
- Daré Bioscience — Sildenafil Cream 3.6%. Checked 13 August 2026.
- Daré Bioscience — DARE to PLAY commercial-access update. Checked 13 August 2026.
Still not sure which HRT program or local treatment path fits your situation? Use Find My HRT Path.
